BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 29397916)

  • 1. [Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer].
    Rousset-Jablonski C; Selle F; Adda-Herzog E; Planchamp F; Selleret L; Pomel C; Chabbert-Buffet N; Daraï E; Pautier P; Trémollières F; Guyon F; Rouzier R; Laurence V; Chopin N; Faure-Conter C; Bentivegna E; Vacher-Lavenu MC; Lhomme C; Floquet A; Treilleux I; Lecuru F; Gouy S; Kalbacher E; Genestie C; de la Motte Rouge T; Ferron G; Devouassoux-Shisheboran M; Kurtz JE; Namer M; Joly F; Pujade-Lauraine E; Grynberg M; Querleu D; Morice P; Gompel A; Ray-Coquard I
    Bull Cancer; 2018 Mar; 105(3):299-314. PubMed ID: 29397916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancers.
    Rousset-Jablonski C; Selle F; Adda-Herzog E; Planchamp F; Selleret L; Pomel C; Daraï E; Chabbert-Buffet N; Pautier P; Trémollières F; Guyon F; Rouzier R; Laurence V; Chopin N; Faure-Conter C; Bentivegna E; Vacher-Lavenu MC; Lhomme C; Floquet A; Treilleux I; Lecuru F; Gouy S; Kalbacher E; Genestie C; Thibault MR; Ferron G; Devouassoux M; Kurtz JE; Provansal M; Namer M; Joly F; Pujade-Lauraine E; Grynberg M; Querleu D; Morice P; Gompel A; Ray-Coquard I
    Eur J Cancer; 2019 Jul; 116():35-44. PubMed ID: 31170563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Borderline Ovarian Tumours: CNGOFS Guidelines for Clinical Practice - Hormonal Contraception and MHT/HRT after Borderline Ovarian Tumour].
    Rousset-Jablonski C; Pautier P; Chopin N
    Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):337-340. PubMed ID: 32004788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation.
    Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; D'argent Mathieu E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
    J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101966. PubMed ID: 33144266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Therapeutic Management of Early Stages].
    Canlorbe G; Lecointre L; Chauvet P; Azaïs H; Fauvet R; Uzan C
    Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):287-303. PubMed ID: 32004786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epithelial ovarian cancer and fertility preservation: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
    Uzan C; Courbiere B; Chabbert-Buffet N
    Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):180-186. PubMed ID: 30704956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Fertility].
    Raad J; Rolland L; Grynberg M; Courbiere B; Mathieu d'Argent E
    Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):330-336. PubMed ID: 32004782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Follow-up of patients treated for an epithelial ovarian cancer, place of hormone replacement therapy and of contraception: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
    Sénéchal C; Akladios C; Bendifallah S; Ouldamer L; Lecuru F; Rousset-Jablonski C
    Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):250-262. PubMed ID: 30685388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference.
    Jang JYA; Yanaihara N; Pujade-Lauraine E; Mikami Y; Oda K; Bookman M; Ledermann J; Shimada M; Kiyokawa T; Kim BG; Matsumura N; Kaku T; Kuroda T; Nagayoshi Y; Kawabata A; Iida Y; Kim JW; Quinn M; Okamoto A
    J Gynecol Oncol; 2017 Jul; 28(4):e54. PubMed ID: 28541641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Short Text].
    Bourdel N; Huchon C; Cendos AW; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chéreau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; Mathieu D'argent E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
    Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):223-235. PubMed ID: 32004780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rare ovarian tumours: therapeutic strategies in 2010, national website observatory for rare ovarian cancers and delineation of referent centers in France].
    Ray-Coquard I; Pautier P; Pujade-Lauraine E; Méeus P; Morice P; Treilleux I; Duvillard P; Alexandre J; Lhommé C; Selle F; Guastalla J
    Bull Cancer; 2010 Jan; 97(1):123-35. PubMed ID: 20007069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Methods and conditions of fertility preservation in early-stage ovarian tumors].
    Szatmári E; Máté S; Sipos N; Szánthó A; Silhavy M; Rigó J
    Orv Hetil; 2013 Apr; 154(14):523-30. PubMed ID: 23545230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spanish consensus on premature menopause.
    Mendoza N; Juliá MD; Galliano D; Coronado P; Díaz B; Fontes J; Gallo JL; García A; Guinot M; Munnamy M; Roca B; Sosa M; Tomás J; Llaneza P; Sánchez-Borrego R
    Maturitas; 2015 Feb; 80(2):220-5. PubMed ID: 25578643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Epidemiology and Risk Factors of Relapse, Follow-up and Interest of a Completion Surgery].
    Margueritte F; Sallee C; Lacorre A; Gauroy E; Larouzee E; Chereau E; De La Motte Rouge T; Koskas M; Gauthier T
    Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):248-259. PubMed ID: 32004784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Préservation de la fertilité avant traitement d'un cancer de l'ovaire].
    Li H; Kolanska K; Prades M; Touboul C; Uzan C; Chabbert Buffet N
    Rev Prat; 2022 Jun; 72(6):621-626. PubMed ID: 35899661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preservation of fertility in surgery of benign and borderline malignant ovarian tumors.
    Guillaume A; Pirrello O
    J Visc Surg; 2018 Jun; 155 Suppl 1():S17-S21. PubMed ID: 29709486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Surgical Management of Advanced Stages of Borderline Ovarian Tumours].
    Raimond E; Bourdel N
    Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):304-313. PubMed ID: 32004785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fertility management for malignant ovarian germ cell tumors patients.
    Di Tucci C; Casorelli A; Morrocchi E; Palaia I; Muzii L; Panici PB
    Crit Rev Oncol Hematol; 2017 Dec; 120():34-42. PubMed ID: 29198336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fertility preservation in rare ovarian tumors.
    Chelariu-Raicu A; Cobb LP; Gershenson DM
    Int J Gynecol Cancer; 2021 Mar; 31(3):432-441. PubMed ID: 33649010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian epithelial tumors and reproductive factors: a systematic review.
    Schüler S; Ponnath M; Engel J; Ortmann O
    Arch Gynecol Obstet; 2013 Jun; 287(6):1187-204. PubMed ID: 23503972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.